Pharmosa Biopharm Inc. (TPEX:6875)

Pharmosa Biopharm Statistics

Total Valuation

TPEX:6875 has a market cap or net worth of TWD 5.08 billion. The enterprise value is 4.05 billion.

Market Cap	5.08B
Enterprise Value	4.05B

Important Dates

The next estimated earnings date is Monday, May 11, 2026.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6875 has 129.09 million shares outstanding. The number of shares has increased by 2.23% in one year.

Current Share Class	129.09M
Shares Outstanding	129.09M
Shares Change (YoY)	+2.23%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	7.12%
Owned by Institutions (%)	2.19%
Float	78.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	75.51
PB Ratio	3.26
P/TBV Ratio	3.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.55
EV / Sales	60.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.50

Financial Position

The company has a current ratio of 12.11, with a Debt / Equity ratio of 0.06.

Current Ratio	12.11
Quick Ratio	11.46
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.21
Interest Coverage	-191.84

Financial Efficiency

Return on equity (ROE) is -21.96% and return on invested capital (ROIC) is -13.56%.

Return on Equity (ROE)	-21.96%
Return on Assets (ROA)	-12.87%
Return on Invested Capital (ROIC)	-13.56%
Return on Capital Employed (ROCE)	-24.43%
Weighted Average Cost of Capital (WACC)	5.70%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	2.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.72% in the last 52 weeks. The beta is 0.28, so TPEX:6875's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-26.72%
50-Day Moving Average	44.17
200-Day Moving Average	46.19
Relative Strength Index (RSI)	40.30
Average Volume (20 Days)	134,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6875 had revenue of TWD 67.27 million and -383.85 million in losses. Loss per share was -2.97.

Revenue	67.27M
Gross Profit	13.03M
Operating Income	-402.86M
Pretax Income	-383.85M
Net Income	-383.85M
EBITDA	-371.37M
EBIT	-402.86M
Loss Per Share	-2.97

Balance Sheet

The company has 1.13 billion in cash and 99.61 million in debt, with a net cash position of 1.03 billion or 7.99 per share.

Cash & Cash Equivalents	1.13B
Total Debt	99.61M
Net Cash	1.03B
Net Cash Per Share	7.99
Equity (Book Value)	1.56B
Book Value Per Share	12.01
Working Capital	1.10B

Cash Flow

In the last 12 months, operating cash flow was -357.48 million and capital expenditures -118.70 million, giving a free cash flow of -476.18 million.

Operating Cash Flow	-357.48M
Capital Expenditures	-118.70M
Depreciation & Amortization	31.48M
Net Borrowing	-17.99M
Free Cash Flow	-476.18M
FCF Per Share	-3.69

Margins

Gross Margin	19.37%
Operating Margin	-598.88%
Pretax Margin	-570.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6875 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.23%
Shareholder Yield	-2.23%
Earnings Yield	-7.56%
FCF Yield	-9.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6875 has an Altman Z-Score of 19.66 and a Piotroski F-Score of 1.

Altman Z-Score	19.66
Piotroski F-Score	1